Drug Information Association (DIA) Japan – 17th Annual Meeting (November 8-10, 2020 – Virtual Meeting)
-
A. Hihara [1]
-
[1] Clarivate, Paris, France
-
- Localización: Medicamentos de actualidad = Drugs of today, ISSN 1699-3993, Vol. 56, Nº. 12, 2020, págs. 787-793
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
As many other conferences held in 2020, the 17th Drug Information Association (DIA) Japan Annual Meeting 2020 was held virtually for the first time due to the COVID-19 crisis. The virtual platform delivered 64 ses-sions across 3 days and allowed participants to join the sessions flexibly, interactively participate in Q&A and connect with fellows without boundaries. The opening speech was addressed by Hajime Saijo (DIA Japan) to introduce the conference theme “Beyond Innovation” and key sessions featured discussionson future healthcare, the International Council for Harmonisation of Technical Requirements for Phar-maceuticals for Human Use (ICH) 30-year anniversary, the Pharmaceuticals and Medical Devices Agency (PMDA) town hall, patient-focused drug development and global drug development. This meeting report covers the topics discussed from the programs fea-turing patient engagement, innovative drug develop-ment and new technologies.
